Parallel Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.4K Sell
1,480
-627
-30% -$19.9K ﹤0.01% 2248
2026
Q1
$66.3K Buy
2,107
+707
+51% +$22.3K ﹤0.01% 1828
2025
Q4
$41.3K Buy
1,400
+32
+2% +$889 ﹤0.01% 1936
2025
Q3
$34.5K Buy
1,368
+236
+21% +$5.75K ﹤0.01% 1981
2025
Q2
$27.2K Buy
1,132
+913
+417% +$21.2K ﹤0.01% 2046
2025
Q1
$5.01K Sell
219
-809
-79% -$19.5K ﹤0.01% 2683
2024
Q4
$26K Sell
1,028
-1,024
-50% -$25.9K ﹤0.01% 2012
2024
Q3
$51.2K Buy
2,052
+300
+17% +$8.88K ﹤0.01% 1624
2024
Q2
$51.9K Buy
1,752
+255
+17% +$7.07K ﹤0.01% 1496
2024
Q1
$45.1K Buy
1,497
+312
+26% +$8.66K ﹤0.01% 1552
2023
Q4
$33.9K Buy
1,185
+391
+49% +$11.5K ﹤0.01% 1636
2023
Q3
$29.4K Buy
794
+236
+42% +$9.02K ﹤0.01% 1657
2023
Q2
$21.8K Sell
558
-333
-37% -$13K ﹤0.01% 1809
2023
Q1
$32.5K Buy
891
+33
+4% +$1.04K ﹤0.01% 1598
2022
Q4
$26.4K Buy
+858
New +$26.6K ﹤0.01% 1582

Other funds holding RTO

Parallel Advisors's RTO Position: Q2 2026 in Review

Parallel Advisors reduced its Rentokil (RTO) stake by 30% in Q2 2026, selling an estimated $19.9K and leaving 1,480 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2248.

Parallel Advisors first reported a position in RTO in Q4 2022 and has held it in 15 quarters since. The position peaked at $66.3K in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Parallel Advisors held 1,480 shares of Rentokil worth $42.4K as of Q2 2026.
  • Parallel Advisors sold 627 Rentokil shares in Q2 2026, an estimated $19.9K.
  • Rentokil made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2248 holding.
  • Parallel Advisors first reported a position in Rentokil in Q4 2022 and has held it in 15 quarters since.
  • Parallel Advisors's Rentokil position peaked at $66.3K in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.